Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Biomarker Study for Salivary Gland Carcinoma

NCT06047236 is registered in ClinicalTrials.gov with University of Erlangen-Nürnberg Medical School as lead sponsor.

NCT NCT06047236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06047236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Biomarker Study for Salivary Gland Carcinoma
Lead sponsor
University of Erlangen-Nürnberg Medical School
Phase
Observational
Overall status
Recruiting
Start date
January 8, 2024
Completion date
September 30, 2031
Enrollment
300 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

benign salivary gland tumor, salivary gland tumor